# Biomedical Ethics and Regulation

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/biomedical-ethics-and-regulation/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the regulation, ethical considerations, and challenges surrounding stem cell therapies and clinics. It covers topics such as patient safety, direct-to-consumer marketing, global governance, translational research, and the ethical implications of unproven therapies. The papers also discuss the need for comprehensive regulatory frameworks to ensure the safe and ethical development of regenerative medicine. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t13417 |
| Works | 83 |

## Topic papers all

Showing 15 of 83.

- [The revision of the Declaration of Helsinki: past, present and future](https://scholariq.org/papers/the-revision-of-the-declaration-of-helsinki-past-present-and-future/)
- [Direct conversion of human fibroblasts to multilineage blood progenitors](https://scholariq.org/papers/direct-conversion-of-human-fibroblasts-to-multilineage-blood-progenitors/)
- [Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus](https://scholariq.org/papers/umbilical-cord-mesenchymal-stem-cell-transplantation-in-severe-and-refractory/)
- [What's the Price of a Research Subject? Approaches to Payment for Research Participation](https://scholariq.org/papers/what-s-the-price-of-a-research-subject-approaches-to-payment-for-research/)
- [The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine](https://scholariq.org/papers/the-multi-functional-roles-of-menstrual-blood-derived-stem-cells-in-regenerative/)
- [No Surgical Innovation Without Evaluation](https://scholariq.org/papers/no-surgical-innovation-without-evaluation/)
- [ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update](https://scholariq.org/papers/isscr-guidelines-for-stem-cell-research-and-clinical-translation-the-2021-update/)
- [Broad Consent for Research With Biological Samples: Workshop Conclusions](https://scholariq.org/papers/broad-consent-for-research-with-biological-samples-workshop-conclusions/)
- [Lancet Commission: Stem cells and regenerative medicine](https://scholariq.org/papers/lancet-commission-stem-cells-and-regenerative-medicine/)
- [Sharing Clinical Trial Data](https://scholariq.org/papers/sharing-clinical-trial-data/)
- [bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine.](https://scholariq.org/papers/bcl-2-deficiency-in-mice-leads-to-pleiotropic-abnormalities-accelerated-lymphoid/)
- [From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients](https://scholariq.org/papers/from-adaptive-licensing-to-adaptive-pathways-delivering-a-flexible-life-span/)
- [Barriers to black women's participation in cancer clinical trials.](https://scholariq.org/papers/barriers-to-black-women-s-participation-in-cancer-clinical-trials/)
- [Data Sharing Statements for Clinical Trials — A Requirement of the International Committee of Medical Journal Editors](https://scholariq.org/papers/data-sharing-statements-for-clinical-trials-a-requirement-of-the-international-2/)
- [How Drugs are Developed and Approved by the FDA: Current Process and Future Directions](https://scholariq.org/papers/how-drugs-are-developed-and-approved-by-the-fda-current-process-and-future/)

## Topic primary papers

- [ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update](https://scholariq.org/papers/isscr-guidelines-for-stem-cell-research-and-clinical-translation-the-2021-update/)
- [Lancet Commission: Stem cells and regenerative medicine](https://scholariq.org/papers/lancet-commission-stem-cells-and-regenerative-medicine/)
- [bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine.](https://scholariq.org/papers/bcl-2-deficiency-in-mice-leads-to-pleiotropic-abnormalities-accelerated-lymphoid/)
- [The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications](https://scholariq.org/papers/the-implementation-of-managed-entry-agreements-in-central-and-eastern-europe/)
- [Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)](https://scholariq.org/papers/clinical-cell-therapy-guidelines-for-neurorestoration-ianr-canr-2017/)
- [Pre-approval Access Terminology: A Cause for Confusion and a Danger to Patients](https://scholariq.org/papers/pre-approval-access-terminology-a-cause-for-confusion-and-a-danger-to-patients/)
- [Which Framework to Use? A Systematic Review of Ethical Frameworks for the Screening or Evaluation of Health Technology Innovations](https://scholariq.org/papers/which-framework-to-use-a-systematic-review-of-ethical-frameworks-for-the/)
- [Use of not authorised stem-cell based products: The Committe for Advanced Therapies (CAT) perspective](https://scholariq.org/papers/use-of-not-authorised-stem-cell-based-products-the-committe-for-advanced/)
- [Global health reciprocal innovation: ethical, legal and regulatory considerations](https://scholariq.org/papers/global-health-reciprocal-innovation-ethical-legal-and-regulatory-considerations/)
- [The Economic Burden of Alopecia Areata in Romania](https://scholariq.org/papers/the-economic-burden-of-alopecia-areata-in-romania/)
- [1886P Quantifying quality of informed consent (IC) in patients enrolled in phase I (ph I) oncology clinical trials with a validated instrument (QuIC Parts A, B) in a large United Kingdom phase I trials unit](https://scholariq.org/papers/1886p-quantifying-quality-of-informed-consent-ic-in-patients-enrolled-in-phase-i/)
- [PBI35 HEALTH TECHNOLOGY ASSESSMENT (HTA) REVIEW OF CELL & GENE THERAPIES: THE ROAD TO REIMBURSEMENT](https://scholariq.org/papers/pbi35-health-technology-assessment-hta-review-of-cell-and-amp-gene-therapies-the/)
- [Patients’ views on paying to participate in clinical trials.](https://scholariq.org/papers/patients-views-on-paying-to-participate-in-clinical-trials/)
- [PT37 Operationalizing an Outcomes-Based MarketAccess Agreement Using Real-World Data From the Canadian Neuromuscular Disease Registry](https://scholariq.org/papers/pt37-operationalizing-an-outcomes-based-marketaccess-agreement-using-real-world/)
- [Safety and compliance among newly qualified paramedics in a pre-hospital clinical trial of an investigational medicinal product: a post-hoc analysis of the PACKMaN randomised controlled trial](https://scholariq.org/papers/safety-and-compliance-among-newly-qualified-paramedics-in-a-pre-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.